Small-scale studies of faecal microbiota transplantation (FMT) have also suggested that engraftment of donor microbiota can improve insulin sensitivity or enhance responses to cancer therapy in selected settings [PMID: 37929014]. The gene discussed is INS; the disease is cancer.